New clinical trial seeks to combat pancreatic cancer

Patients with pancreatic cancer might consider joining a Phase II clinical trial underway at Baylor University Medical Center, part of Baylor Scott & White Health, to evaluate a new chemotherapy protocol. The trial will study the effectiveness of a particular therapy in patients with non-metastatic disease. “Our primary objective with this trial is to try … Continue reading New clinical trial seeks to combat pancreatic cancer

New Blood Test Could Eliminate the Need for Screening Colonoscopies

Imagine a world without routine colonoscopies. Because of a new blood test we developed at Baylor Research Institute, this could potentially become a reality. Our team of researchers at the Gastrointestinal Cancer Research Lab has spent the last several years working on the discovery and validation of biomarkers that can facilitate the early detection of … Continue reading New Blood Test Could Eliminate the Need for Screening Colonoscopies

Ovarian Cancer’s Vulnerability Exposed: Clinical Trial Offers New Hope

Targeted therapy for ovarian cancer has been an elusive goal for researchers for many years because ovarian cancer is a heterogeneous disease, exhibiting a plethora of genetic alterations. In a small percentage of patients, the cancer is found to be hereditary. In these patients, mutations in the BRCA gene lead to an increased risk of ovarian, … Continue reading Ovarian Cancer’s Vulnerability Exposed: Clinical Trial Offers New Hope

4 Things to Know About The New Breast Cancer “Smart Bomb”

The experimental drug, T-DM1, also known as the breast cancer “smart bomb,” is a phrase that’s been on everyone’s lips and search engines since Monday when it was announced as the “miracle drug” breast cancer treatment. Kimberly Blackwell, M.D., an oncologist at Duke University Medical Center and lead investigator of the T-DM1 study, presented her … Continue reading 4 Things to Know About The New Breast Cancer “Smart Bomb”